Literature DB >> 2473613

Radiographic contrast media-induced histamine release: a comparative study with mast cells from different species.

E U Amon1, M Ennis, M Schnabel, C Schneider, W Lorenz.   

Abstract

Radiographic contrast media in clinical use cause unwanted allergic and pseudoallergic reactions. To investigate the mechanisms of these reactions, studies on isolated mast cells from different species and sites are necessary. In this study, the effect of six commonly used contrast media on rat (peritoneal, lung) and human (lung) mast cells was investigated. The three preparations with low osmolalities (Hexabrix, Solutrast, Ultravist) released little or no histamine from the cells examined. In contrast, the three preparations with high osmolalities (Angiographin, Telebrix, Rayvist) were potent releasing agents. However, the degree of release and the order of potency was different depending on the cells investigated. Indeed, rat peritoneal mast cells required much higher concentrations before release was observed. Since the contrast media with low osmolality also cause histamine release and reactions in vivo, other systems (e.g. complement) must be additionally involved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473613     DOI: 10.1007/bf02222211

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  [Side effects and complications following administration of roentgen contrast media--reducing the risk and prevention].

Authors:  H K Beyer; R Kukulies; W G Schmitt; B Schulze
Journal:  Rontgenpraxis       Date:  1987-12

2.  Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material.

Authors:  E C Lasser; C C Berry; L B Talner; L C Santini; E K Lang; F H Gerber; H O Stolberg
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

3.  Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells.

Authors:  F L Pearce; M Ennis; A Truneh; J R White
Journal:  Agents Actions       Date:  1981-04

4.  Histamine release from canine lung and liver mast cells induced by radiographic contrast media.

Authors:  M Ennis; E U Amon; W Lorenz
Journal:  Agents Actions       Date:  1989-04

5.  Influence of anions, cations and osmolarity on IgE-mediated histamine release from human basophils.

Authors:  W A Hook; R P Siraganian
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

6.  Histamine release from human pulmonary mast cells.

Authors:  M Ennis
Journal:  Agents Actions       Date:  1982-04

7.  Adverse reactions during intravenous urography: are these due to histamine release?

Authors:  C M Herd; A R Robertson; D B Frewin; W B Taylor
Journal:  Br J Radiol       Date:  1988-01       Impact factor: 3.039

8.  In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells.

Authors:  J Ring; C M Arroyave; M J Frizler; E M Tan
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

  8 in total
  4 in total

Review 1.  Reactions to radiocontrast material. Anaphylactoid events in radiology.

Authors:  P L Lieberman; R L Seigle
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Roles of intracellular Ca2+ and cyclic AMP in mast cell histamine release induced by radiographic contrast media.

Authors:  Mami Saito; Yoshinori Itoh; Takahisa Yano; Toshiaki Sendo; Takeshi Goromaru; Naoko Sakai; Ryozo Oishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-06       Impact factor: 3.000

Review 3.  Anaphylactoid reactions to radiocontrast material.

Authors:  P Lieberman
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

4.  Histamine release and pseudoallergic reactions induced by radiographic contrast media: comparison of Angiographin, Hexabrix and Telebrix using an in vivo canine model.

Authors:  M Ennis; W Lorenz; A Schmal; H Dombrowski
Journal:  Agents Actions       Date:  1990-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.